Download apical hypertrophic cardiomyopathy with a rare mybpc3 gene

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Site-specific recombinase technology wikipedia , lookup

Epigenetics of diabetes Type 2 wikipedia , lookup

Genome evolution wikipedia , lookup

Gene therapy wikipedia , lookup

RNA-Seq wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

History of genetic engineering wikipedia , lookup

Genetic testing wikipedia , lookup

Genetic engineering wikipedia , lookup

Nutriepigenomics wikipedia , lookup

Epigenetics of neurodegenerative diseases wikipedia , lookup

Mutation wikipedia , lookup

Gene therapy of the human retina wikipedia , lookup

Epistasis wikipedia , lookup

Medical genetics wikipedia , lookup

Gene expression profiling wikipedia , lookup

Neuronal ceroid lipofuscinosis wikipedia , lookup

Population genetics wikipedia , lookup

Pharmacogenomics wikipedia , lookup

Gene expression programming wikipedia , lookup

Point mutation wikipedia , lookup

Designer baby wikipedia , lookup

Public health genomics wikipedia , lookup

Frameshift mutation wikipedia , lookup

Genome (book) wikipedia , lookup

Microevolution wikipedia , lookup

Transcript
1521, oral or poster, cat: 4
APICAL HYPERTROPHIC CARDIOMYOPATHY WITH A RARE MYBPC3
GENE MUTATION VARIANT
P.T. Bhattacharya1, T.A. Ahmad1, M.A. Bataineh2
1
Mercy Catholic Medical Center, Drexel University, Philadelphia, PA, 2Drexel
University, Philadelphia, PA, USA
Apical hypertrophic cardiomyopathy (HCM) is a unique form of HCM that is
localized to the left ventricular apex with approximately 30% of patients found to be
genotype positive that most often involve MYBPC3 and MYH7 genes. These patients
are more likely to have family history for hypertrophic cardiomyopathy (HCM) but no
additional HCM-related events are so far described. We are reporting a rare
symptomatic patient with apical HCM who has MYBPC3 p.Gly596Arg mutation that
was reported only once under the category of variant of unknown significance. A 49
year old male with no past medical history, presented with left sided chest pain. He
has no family history of sudden cardiac death, syncope or cardiomyopathy. A 12-lead
electrocardiogram revealed left ventricular (LV) hypertrophy and deep T wave
inversions on anterolateral leads. Transthoracic echocardiogram showed a “spadeshaped” left ventricular apical hypertrophy, impaired diastolic relaxation, and
preserved systolic function. Left heart catheterization showed elevated left ventricular
end diastolic pressure of 20 mmHg and normal epicardial coronary arteries.LV
angiogram showed apical hypertrophy with a spade-shaped left ventricle. Outpatient
event monitor revealed 18 beat run of monomorphic non-sustained ventricular
tachycardia and ventricular couplets. He had inducible polymorphic ventricular
tachycardia by electrophysiology study and underwent implantation of an automatic
implantable cardioverter defibrillator for the prevention of sudden cardiac death.
Genetic testing revealed MYBPC3 p.Gly596Arg mutation.
Conclusion: Apical HCM is a unique variant of HCM where in reporting of genomewide association studies and gene expression profiling are needed for better
understanding of the genetic etiology of this disease.